Chapter 17: Central Nervous System Stimulant Drugs

The central nervous system, consisting of the brain and spinal cord, serves as the primary processing center for the body, while the peripheral nervous system manages voluntary movements and involuntary visceral functions through the somatic and autonomic systems. A critical distinction is made between the sympathetic adrenergic response, which is driven by norepinephrine and facilitates excitability, and the parasympathetic cholinergic response, which is mediated by acetylcholine to promote inhibition. The discussion categorizes stimulants into three primary groups: amphetamines, anorexiants, and analeptics. Amphetamines and related medications, such as methylphenidate and modafinil, are primarily utilized to manage attention-deficit/hyperactivity disorder (ADHD) and narcolepsy by modulating the neurotransmitters dopamine and norepinephrine to enhance focus, cognitive performance, and wakefulness. Anorexiants target the brain's satiety centers in the hypothalamus and limbic regions to assist in weight management, though they are generally restricted to short-term use due to the high potential for abuse and cardiovascular side effects like hypertension and tachycardia. Analeptics, including methylxanthines like caffeine, are specialized for stimulating the brain stem and medulla to support respiratory function, particularly in cases of neonatal apnea or respiratory distress. Throughout the text, the nursing process is emphasized, highlighting the necessity of monitoring vital signs, assessing growth in pediatric patients, and educating individuals on the risks of insomnia, weight loss, and potential withdrawal. Clinical judgment is essential when managing these medications, ensuring that patients avoid dietary triggers like excessive caffeine and follow strict tapering protocols to prevent adverse neurological or cardiovascular outcomes.